Which of the following is true regarding the management of Barrett's oesophagus with no dysplasia?

Which of the following is true regarding the management of Barrett's oesophagus with no dysplasia?

• A. It requires endoscopic surveillance
• B. Immediate esophagectomy
• C. No monitoring is needed
• D. Proton pump inhibitors alone

Answer: (A)

The main idea is that Barrett’s esophagus without dysplasia is a premalignant condition that still has a risk, albeit small, of progressing to cancer. Because of that risk, the appropriate management is regular endoscopic surveillance with biopsies to look for any development of dysplasia or early cancer. This allows early intervention if changes occur. Immediate esophagectomy would be far too aggressive for nondysplastic Barrett’s, since surgery carries significant risks and is reserved for cases with high-grade dysplasia or confirmed cancer. Not monitoring isn’t acceptable because changes can develop over time and would be missed without follow-up. Proton pump inhibitors can help control reflux and mucosal symptoms, but they don’t replace the need for surveillance or alter cancer risk by themselves.

The main idea is that Barrett’s esophagus without dysplasia is a premalignant condition that still has a risk, albeit small, of progressing to cancer. Because of that risk, the appropriate management is regular endoscopic surveillance with biopsies to look for any development of dysplasia or early cancer. This allows early intervention if changes occur. Immediate esophagectomy would be far too aggressive for nondysplastic Barrett’s, since surgery carries significant risks and is reserved for cases with high-grade dysplasia or confirmed cancer. Not monitoring isn’t acceptable because changes can develop over time and would be missed without follow-up. Proton pump inhibitors can help control reflux and mucosal symptoms, but they don’t replace the need for surveillance or alter cancer risk by themselves.